Use of Ketamine in Severe Pain Syndromes
CompletedNCT06537375
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Ketamine has been shown to have a certain efficiency in chronic pain syndromes. However, it is still not clearly known what is its efficiency and how ketamine is used in real world patients. In this retrospective study, all patients treated with ketamine for chronic pain in our hospital will be reviewed. Patients demographics, pain syndromes as well as outcome criteria will be collected to describe the use of ketamine in pain syndromes.
Study details
- Official title
- Use of Intravenous Ketamine in Patients with Severe Chronic Pain Syndromes
- Sponsor
- Erasme University Hospital
- Start date
- 2024-08-01
- Primary completion
- 2025-02-20
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: \- All patients who received ketamine as treatment for a pain syndrome during january 2010 until june 2024 at Erasme University Hospital Exclusion Criteria: * Age \< 18 years * Patients who expressed their opposition to the use of their medical data * incomplete medical chart
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06537375